ATAI Life Sciences
ATAI
ATAI
87 hedge funds and large institutions have $79.4M invested in ATAI Life Sciences in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $109M → $79.4M (-$30M)
82% less call options, than puts
Call options by funds: $1.58M | Put options by funds: $8.73M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
87
Holding in Top 10
–
Calls
$1.58M
Puts
$8.73M
Top Buyers
| 1 | +$8.53M | |
| 2 | +$3.69M | |
| 3 | +$1.8M | |
| 4 |
HCA
Hyperion Capital Advisors
New York
|
+$857K |
| 5 |
Renaissance Technologies
New York
|
+$709K |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$2.98M | |
| 3 | -$2.2M | |
| 4 |
Millennium Management
New York
|
-$1.9M |
| 5 |
Walleye Capital
New York
|
-$867K |